FDLI Webinar: Biologic and Biosimilar Litigation and IP Rights
April 27, 2021

On April 27, Axinn partner Chad Landmon spoke at the FDLI webinar, "Biologic and Biosimilar Litigation and IP Rights." Speakers discussed recent case law related to patent term exclusivity, United States Patent and Trademark Office (USPTO) proceedings, and important recent and pending Courts of Appeal decisions.

Click here for more information.

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.